APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Cloning Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Cloning Service Market Analysis and Forecast 2026-2032

1 January 2026200 pages

Choose your research edition.

Industry ResearchGene Cloning Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Cloning Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Gene Cloning Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Cloning Service Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Cloning Service Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Gene Cloning Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Cloning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Cloning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Cloning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Cloning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Cloning Service include Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Charles River Laboratories, Lonza, Sartorius AG and Creative Biogene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Cloning Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Cloning Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Cloning Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Cloning Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Cloning Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Cloning Service revenue, projected growth trends, production technology, application and end-user industry.

Gene Cloning Service Segment by Company

Thermo Fisher Scientific Inc.

Eurofins Scientific

GenScript

Merck KGaA

Takara Bio Inc.

Charles River Laboratories

Lonza

Sartorius AG

Creative Biogene

Cellecta, Inc.

Synbio Technologies

TransGen Biotech Co., Ltd.

Dobuss(Canvax)

Azenta US, Inc.

Macrogen, Inc.

Codex DNA, Inc.

Gene Cloning Service Segment by Type

Stranded Gene

Complex Gene

Others

Gene Cloning Service Segment by Application

Gene Synthesis

Gene Expression

Gene Therapy

Vaccine Research

Others

Gene Cloning Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Cloning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Cloning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Cloning Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Cloning Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Cloning Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Cloning Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Cloning Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stranded Gene Major Player Table 3. Complex Gene Major Player Table 4. Others Major Player Table 5. Global Gene Cloning Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Gene Synthesis Major Player Table 7. Gene Expression Major Player Table 8. Gene Therapy Major Player Table 9. Vaccine Research Major Player Table 10. Others Major Player Table 11. Gene Cloning Service Industry Trends Table 12. Gene Cloning Service Industry Drivers Table 13. Gene Cloning Service Industry Opportunities and Challenges Table 14. Gene Cloning Service Industry Restraints Table 15. Global Gene Cloning Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Gene Cloning Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Gene Cloning Service Market Share by Region (2021-2026) Table 18. Global Gene Cloning Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Gene Cloning Service Market Share by Region (2027-2032) Table 20. Global Gene Cloning Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Gene Cloning Service Revenue Market Share by Players (2021-2026) Table 22. Global Gene Cloning Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Gene Cloning Service Key Players Headquarters & Area Served Table 24. Global Gene Cloning Service Players, Product Type & Application Table 25. Global Gene Cloning Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Gene Cloning Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Gene Cloning Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Gene Cloning Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Gene Cloning Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Gene Cloning Service Revenue Market Share by Type (2021-2026) Table 32. Global Gene Cloning Service Revenue Market Share by Type (2027-2032) Table 33. Global Gene Cloning Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Gene Cloning Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Gene Cloning Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Gene Cloning Service Revenue Market Share by Application (2021-2026) Table 37. Global Gene Cloning Service Revenue Market Share by Application (2027-2032) Table 38. Thermo Fisher Scientific Inc. Company Information Table 39. Thermo Fisher Scientific Inc. Business Overview Table 40. Thermo Fisher Scientific Inc. Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Thermo Fisher Scientific Inc. Gene Cloning Service Product Portfolio Table 42. Thermo Fisher Scientific Inc. Recent Development Table 43. Eurofins Scientific Company Information Table 44. Eurofins Scientific Business Overview Table 45. Eurofins Scientific Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Eurofins Scientific Gene Cloning Service Product Portfolio Table 47. Eurofins Scientific Recent Development Table 48. GenScript Company Information Table 49. GenScript Business Overview Table 50. GenScript Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. GenScript Gene Cloning Service Product Portfolio Table 52. GenScript Recent Development Table 53. Merck KGaA Company Information Table 54. Merck KGaA Business Overview Table 55. Merck KGaA Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Merck KGaA Gene Cloning Service Product Portfolio Table 57. Merck KGaA Recent Development Table 58. Takara Bio Inc. Company Information Table 59. Takara Bio Inc. Business Overview Table 60. Takara Bio Inc. Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Takara Bio Inc. Gene Cloning Service Product Portfolio Table 62. Takara Bio Inc. Recent Development Table 63. Charles River Laboratories Company Information Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Charles River Laboratories Gene Cloning Service Product Portfolio Table 67. Charles River Laboratories Recent Development Table 68. Lonza Company Information Table 69. Lonza Business Overview Table 70. Lonza Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Lonza Gene Cloning Service Product Portfolio Table 72. Lonza Recent Development Table 73. Sartorius AG Company Information Table 74. Sartorius AG Business Overview Table 75. Sartorius AG Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Sartorius AG Gene Cloning Service Product Portfolio Table 77. Sartorius AG Recent Development Table 78. Creative Biogene Company Information Table 79. Creative Biogene Business Overview Table 80. Creative Biogene Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Creative Biogene Gene Cloning Service Product Portfolio Table 82. Creative Biogene Recent Development Table 83. Cellecta, Inc. Company Information Table 84. Cellecta, Inc. Business Overview Table 85. Cellecta, Inc. Gene Cloning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Cellecta, Inc. Gene Cloning Service Product Portfolio Table 87. Cellecta, Inc. Recent Development Table 88. Synbio Technologies Company Information Table 89. Synbio Technologies Business Overview Table 90. Synbio Technologies Gene Cloning Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Synbio Technologies Gene Cloning Service Product Portfolio Table 92. Synbio Technologies Recent Development Table 93. TransGen Biotech Co., Ltd. Company Information Table 94. TransGen Biotech Co., Ltd. Business Overview Table 95. TransGen Biotech Co., Ltd. Gene Cloning Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. TransGen Biotech Co., Ltd. Gene Cloning Service Product Portfolio Table 97. TransGen Biotech Co., Ltd. Recent Development Table 98. Dobuss(Canvax) Company Information Table 99. Dobuss(Canvax) Business Overview Table 100. Dobuss(Canvax) Gene Cloning Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Dobuss(Canvax) Gene Cloning Service Product Portfolio Table 102. Dobuss(Canvax) Recent Development Table 103. Azenta US, Inc. Company Information Table 104. Azenta US, Inc. Business Overview Table 105. Azenta US, Inc. Gene Cloning Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Azenta US, Inc. Gene Cloning Service Product Portfolio Table 107. Azenta US, Inc. Recent Development Table 108. Macrogen, Inc. Company Information Table 109. Macrogen, Inc. Business Overview Table 110. Macrogen, Inc. Gene Cloning Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Macrogen, Inc. Gene Cloning Service Product Portfolio Table 112. Macrogen, Inc. Recent Development Table 113. Codex DNA, Inc. Company Information Table 114. Codex DNA, Inc. Business Overview Table 115. Codex DNA, Inc. Gene Cloning Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Codex DNA, Inc. Gene Cloning Service Product Portfolio Table 117. Codex DNA, Inc. Recent Development Table 118. North America Gene Cloning Service Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Gene Cloning Service Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Gene Cloning Service Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Gene Cloning Service Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. North America Gene Cloning Service Revenue by Country (2021-2026) & (US$ Million) Table 124. North America Gene Cloning Service Revenue by Country (US$ Million) & (2027-2032) Table 125. Europe Gene Cloning Service Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Gene Cloning Service Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Gene Cloning Service Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Gene Cloning Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Gene Cloning Service Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Gene Cloning Service Revenue by Country (US$ Million) & (2027-2032) Table 132. China Gene Cloning Service Revenue by Type (2021-2026) & (US$ Million) Table 133. China Gene Cloning Service Revenue by Type (2027-2032) & (US$ Million) Table 134. China Gene Cloning Service Revenue by Application (2021-2026) & (US$ Million) Table 135. China Gene Cloning Service Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Gene Cloning Service Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Gene Cloning Service Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Gene Cloning Service Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Gene Cloning Service Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Gene Cloning Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Gene Cloning Service Revenue by Region (US$ Million) & (2021-2026) Table 142. Asia Gene Cloning Service Revenue by Region (US$ Million) & (2027-2032) Table 143. SAMEA Gene Cloning Service Revenue by Type (2021-2026) & (US$ Million) Table 144. SAMEA Gene Cloning Service Revenue by Type (2027-2032) & (US$ Million) Table 145. SAMEA Gene Cloning Service Revenue by Application (2021-2026) & (US$ Million) Table 146. SAMEA Gene Cloning Service Revenue by Application (2027-2032) & (US$ Million) Table 147. SAMEA Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. SAMEA Gene Cloning Service Revenue by Country (2021-2026) & (US$ Million) Table 149. SAMEA Gene Cloning Service Revenue by Country (US$ Million) & (2027-2032) Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Gene Cloning Service Image Figure 2. Global Gene Cloning Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Cloning Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stranded Gene Image Figure 5. Complex Gene Image Figure 6. Others Image Figure 7. Global Gene Cloning Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gene Cloning Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Gene Synthesis Image Figure 10. Gene Expression Image Figure 11. Gene Therapy Image Figure 12. Vaccine Research Image Figure 13. Others Image Figure 14. Global Gene Cloning Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Gene Cloning Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Gene Cloning Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Gene Cloning Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gene Cloning Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Cloning Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gene Cloning Service Revenue Market Share by Type (2021-2032) Figure 22. Global Gene Cloning Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gene Cloning Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Gene Cloning Service Revenue Market Share by Application (2021-2032) Figure 25. North America Gene Cloning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Gene Cloning Service Revenue Share by Type (2021-2032) Figure 27. North America Gene Cloning Service Revenue Share by Application (2021-2032) Figure 28. North America Gene Cloning Service Revenue Share by Country (2021-2032) Figure 29. United States Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Gene Cloning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Gene Cloning Service Revenue Share by Type (2021-2032) Figure 34. Europe Gene Cloning Service Revenue Share by Application (2021-2032) Figure 35. Europe Gene Cloning Service Revenue Share by Country (2021-2032) Figure 36. Germany Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Gene Cloning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Gene Cloning Service Revenue Share by Type (2021-2032) Figure 46. China Gene Cloning Service Revenue Share by Application (2021-2032) Figure 47. Asia Gene Cloning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Gene Cloning Service Revenue Share by Type (2021-2032) Figure 49. Asia Gene Cloning Service Revenue Share by Application (2021-2032) Figure 50. Asia Gene Cloning Service Revenue Share by Region (2021-2032) Figure 51. Japan Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Gene Cloning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Gene Cloning Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Gene Cloning Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Gene Cloning Service Revenue Share by Country (2021-2032) Figure 61. Brazil Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Gene Cloning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Stranded Gene
  • Complex Gene
  • Others
Applications
  • Gene Synthesis
  • Gene Expression
  • Gene Therapy
  • Vaccine Research
  • Others
Companies covered
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • GenScript
  • Merck KGaA
  • Takara Bio Inc.
  • Charles River Laboratories
  • Lonza
  • Sartorius AG
  • Creative Biogene
  • Cellecta, Inc.
  • Synbio Technologies
  • TransGen Biotech Co., Ltd.
  • Dobuss(Canvax)
  • Azenta US, Inc.
  • Macrogen, Inc.
  • Codex DNA, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Cloning Service Market by Type
  3. 1.2.1 Global Gene Cloning Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stranded Gene
  5. 1.2.3 Complex Gene
  6. 1.2.4 Others
  7. 1.3 Gene Cloning Service Market by Application
  8. 1.3.1 Global Gene Cloning Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Gene Synthesis
  10. 1.3.3 Gene Expression
  11. 1.3.4 Gene Therapy
  12. 1.3.5 Vaccine Research
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gene Cloning Service Market Dynamics
  1. 2.1 Gene Cloning Service Industry Trends
  2. 2.2 Gene Cloning Service Industry Drivers
  3. 2.3 Gene Cloning Service Industry Opportunities and Challenges
  4. 2.4 Gene Cloning Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Cloning Service Market Perspective (2021-2032)
  2. 3.2 Global Gene Cloning Service Growth Trends by Region
  3. 3.2.1 Global Gene Cloning Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Cloning Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Cloning Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Cloning Service Revenue by Players
  2. 4.1.1 Global Gene Cloning Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Cloning Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Cloning Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Cloning Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Cloning Service Key Players Headquarters & Area Served
  7. 4.4 Global Gene Cloning Service Players, Product Type & Application
  8. 4.5 Global Gene Cloning Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Cloning Service Market CR5 and HHI
  11. 4.6.3 2025 Gene Cloning Service Tier 1, Tier 2, and Tier 3
5 Gene Cloning Service Market Size by Type
  1. 5.1 Global Gene Cloning Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Cloning Service Revenue by Type (2021-2032)
  3. 5.3 Global Gene Cloning Service Revenue Market Share by Type (2021-2032)
6 Gene Cloning Service Market Size by Application
  1. 6.1 Global Gene Cloning Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Cloning Service Revenue by Application (2021-2032)
  3. 6.3 Global Gene Cloning Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific Inc.
  2. 7.1.1 Thermo Fisher Scientific Inc. Company Information
  3. 7.1.2 Thermo Fisher Scientific Inc. Business Overview
  4. 7.1.3 Thermo Fisher Scientific Inc. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Inc. Gene Cloning Service Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Inc. Recent Developments
  7. 7.2 Eurofins Scientific
  8. 7.2.1 Eurofins Scientific Company Information
  9. 7.2.2 Eurofins Scientific Business Overview
  10. 7.2.3 Eurofins Scientific Gene Cloning Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurofins Scientific Gene Cloning Service Product Portfolio
  12. 7.2.5 Eurofins Scientific Recent Developments
  13. 7.3 GenScript
  14. 7.3.1 GenScript Company Information
  15. 7.3.2 GenScript Business Overview
  16. 7.3.3 GenScript Gene Cloning Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GenScript Gene Cloning Service Product Portfolio
  18. 7.3.5 GenScript Recent Developments
  19. 7.4 Merck KGaA
  20. 7.4.1 Merck KGaA Company Information
  21. 7.4.2 Merck KGaA Business Overview
  22. 7.4.3 Merck KGaA Gene Cloning Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck KGaA Gene Cloning Service Product Portfolio
  24. 7.4.5 Merck KGaA Recent Developments
  25. 7.5 Takara Bio Inc.
  26. 7.5.1 Takara Bio Inc. Company Information
  27. 7.5.2 Takara Bio Inc. Business Overview
  28. 7.5.3 Takara Bio Inc. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Takara Bio Inc. Gene Cloning Service Product Portfolio
  30. 7.5.5 Takara Bio Inc. Recent Developments
  31. 7.6 Charles River Laboratories
  32. 7.6.1 Charles River Laboratories Company Information
  33. 7.6.2 Charles River Laboratories Business Overview
  34. 7.6.3 Charles River Laboratories Gene Cloning Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Charles River Laboratories Gene Cloning Service Product Portfolio
  36. 7.6.5 Charles River Laboratories Recent Developments
  37. 7.7 Lonza
  38. 7.7.1 Lonza Company Information
  39. 7.7.2 Lonza Business Overview
  40. 7.7.3 Lonza Gene Cloning Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lonza Gene Cloning Service Product Portfolio
  42. 7.7.5 Lonza Recent Developments
  43. 7.8 Sartorius AG
  44. 7.8.1 Sartorius AG Company Information
  45. 7.8.2 Sartorius AG Business Overview
  46. 7.8.3 Sartorius AG Gene Cloning Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sartorius AG Gene Cloning Service Product Portfolio
  48. 7.8.5 Sartorius AG Recent Developments
  49. 7.9 Creative Biogene
  50. 7.9.1 Creative Biogene Company Information
  51. 7.9.2 Creative Biogene Business Overview
  52. 7.9.3 Creative Biogene Gene Cloning Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Biogene Gene Cloning Service Product Portfolio
  54. 7.9.5 Creative Biogene Recent Developments
  55. 7.10 Cellecta, Inc.
  56. 7.10.1 Cellecta, Inc. Company Information
  57. 7.10.2 Cellecta, Inc. Business Overview
  58. 7.10.3 Cellecta, Inc. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cellecta, Inc. Gene Cloning Service Product Portfolio
  60. 7.10.5 Cellecta, Inc. Recent Developments
  61. 7.11 Synbio Technologies
  62. 7.11.1 Synbio Technologies Company Information
  63. 7.11.2 Synbio Technologies Business Overview
  64. 7.11.3 Synbio Technologies Gene Cloning Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Synbio Technologies Gene Cloning Service Product Portfolio
  66. 7.11.5 Synbio Technologies Recent Developments
  67. 7.12 TransGen Biotech Co., Ltd.
  68. 7.12.1 TransGen Biotech Co., Ltd. Company Information
  69. 7.12.2 TransGen Biotech Co., Ltd. Business Overview
  70. 7.12.3 TransGen Biotech Co., Ltd. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 TransGen Biotech Co., Ltd. Gene Cloning Service Product Portfolio
  72. 7.12.5 TransGen Biotech Co., Ltd. Recent Developments
  73. 7.13 Dobuss(Canvax)
  74. 7.13.1 Dobuss(Canvax) Company Information
  75. 7.13.2 Dobuss(Canvax) Business Overview
  76. 7.13.3 Dobuss(Canvax) Gene Cloning Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Dobuss(Canvax) Gene Cloning Service Product Portfolio
  78. 7.13.5 Dobuss(Canvax) Recent Developments
  79. 7.14 Azenta US, Inc.
  80. 7.14.1 Azenta US, Inc. Company Information
  81. 7.14.2 Azenta US, Inc. Business Overview
  82. 7.14.3 Azenta US, Inc. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Azenta US, Inc. Gene Cloning Service Product Portfolio
  84. 7.14.5 Azenta US, Inc. Recent Developments
  85. 7.15 Macrogen, Inc.
  86. 7.15.1 Macrogen, Inc. Company Information
  87. 7.15.2 Macrogen, Inc. Business Overview
  88. 7.15.3 Macrogen, Inc. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Macrogen, Inc. Gene Cloning Service Product Portfolio
  90. 7.15.5 Macrogen, Inc. Recent Developments
  91. 7.16 Codex DNA, Inc.
  92. 7.16.1 Codex DNA, Inc. Company Information
  93. 7.16.2 Codex DNA, Inc. Business Overview
  94. 7.16.3 Codex DNA, Inc. Gene Cloning Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Codex DNA, Inc. Gene Cloning Service Product Portfolio
  96. 7.16.5 Codex DNA, Inc. Recent Developments
8 North America
  1. 8.1 North America Gene Cloning Service Revenue (2021-2032)
  2. 8.2 North America Gene Cloning Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Cloning Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Cloning Service Revenue by Type (2027-2032)
  5. 8.3 North America Gene Cloning Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Cloning Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Cloning Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Cloning Service Revenue by Application (2027-2032)
  9. 8.5 North America Gene Cloning Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Cloning Service Revenue by Country
  11. 8.6.1 North America Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Cloning Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Cloning Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gene Cloning Service Revenue (2021-2032)
  2. 9.2 Europe Gene Cloning Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Cloning Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Cloning Service Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Cloning Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Cloning Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Cloning Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Cloning Service Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Cloning Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Cloning Service Revenue by Country
  11. 9.6.1 Europe Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Cloning Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Cloning Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gene Cloning Service Revenue (2021-2032)
  2. 10.2 China Gene Cloning Service Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Cloning Service Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Cloning Service Revenue by Type (2027-2032)
  5. 10.3 China Gene Cloning Service Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Cloning Service Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Cloning Service Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Cloning Service Revenue by Application (2027-2032)
  9. 10.5 China Gene Cloning Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Cloning Service Revenue (2021-2032)
  2. 11.2 Asia Gene Cloning Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Cloning Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Cloning Service Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Cloning Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Cloning Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Cloning Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Cloning Service Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Cloning Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Cloning Service Revenue by Country
  11. 11.6.1 Asia Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Cloning Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Cloning Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Cloning Service Revenue (2021-2032)
  2. 12.2 SAMEA Gene Cloning Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Cloning Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Cloning Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Cloning Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Cloning Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Cloning Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Cloning Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Cloning Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Cloning Service Revenue by Country
  11. 12.6.1 SAMEA Gene Cloning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Cloning Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Cloning Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst